Name: free-hand intracerebroventricular injections in mice
Uploaded: 2024-01-12T12:45:00.000+00:00
Duration: 5 min 29 s
Description: Watch this Scientific Journal Video about Insights, Innovations, and Future Avenues in Reproductive Neurocontrol at JoVE.com

We would like to thank Dr. Kellie Breen Church, Mr. Michael Kreisman, and Ms. Jessica Jang for their contributions to collecting the data shown in the representative results. This work was supported by the National Institutes of Health (NIH) R00 HD104994 (R.B.M.).

All the procedures were approved by the Colorado State University (#3960) and University of California San Diego Institutional Animal Care and Use Committees, where the representative data were collected (S13235, PI Kellie Breen Church). Data from five adult female and two adult male C57/BL6 mice (9-16 weeks old) are depicted in the representative data section. Female mice were ovariectomized 3-4 weeks prior to ICV injection and blood collection as described previously7. Prior to experimentation, these mice were housed with a 12 h light/12 h dark light cycle and had free access to feed and water in accordance with the Guide for the Care and Use of Laboratory Animals.
1. Performing craniotomy
NOTE: Craniotomy can be performed one or more days prior to the actual injection, which makes the injection process quicker on the day of the experiment.
<ol>
	<li>Prepare the materials for the craniotomy as described below.
	<ol>
		<li>Place a clean bench pad or drape material on the work surface. Tape the nose cone of an isoflurane vaporizer to the work surface (close to, but facing away from, the experimenter; see Figure 1A).</li>
		<li>Place silastic tubing on the end of a sterile sharp 18 G needle so that ~1 mm of the needle tip protrudes. Place silastic tubing on the end of a sterile blunt needle so that ~1 mm of the needle tip protrudes. 
		NOTE: Separate and sterile pre-packaged needles (sharp and blunt) should be used for each mouse.</li>
		<li>Gather an electric shaver, iodine scrub, sterile gauze, and alcohol pads for preparing the injection site.</li>
	</ol>
	</li>
	<li>Practice moving a needle 2 mm lateral and 1 mm caudal as described below.
	<ol>
		<li>Use a ruler and a pen to mark a sheet of paper with a starting point (this will be bregma), a mark 2 mm to either the left or right, and another mark 1 mm above the last one (this will be the injection site; see Figure 1B).</li>
		<li>Practice moving the needle from the starting point to mark point 1 to mark point 2 (bregma to injection site) until confident that the movement is repeatable without guides. 
		NOTE: The coordinates described here are effective in adult C57/BL6 mice, but other strains or age groups may require adjustment.</li>
	</ol>
	</li>
	<li>Prepare the mouse for craniotomy as described below.
	<ol>
		<li>Place the mouse in an induction chamber and anesthetize the mouse with 3%-4% isoflurane in medical-grade oxygen. With practice and familiarity with the procedure, reduce the total duration of isoflurane exposure to less than 10 min for the craniotomy procedure. 
		CAUTION: Isoflurane exposure is hazardous to human health; use an approved and inspected isoflurane vaporizer in a well-ventilated area with means of scavenging waste gases.</li>
		<li>Once the toe reflex is absent, shave the head of the animal. Apply eye lubricant.</li>
		<li>Place the mouse on the work surface with the head in the nose cone to maintain anesthesia.</li>
		<li>Administer an analgesic agent, such as buprenorphine (0.6-0.8 mg/kg mouse body weight, subcutaneously), as directed by the supplier.</li>
		<li>Clean the injection site by wiping the head with sterile gauze dipped in an iodine solution (perform three scrubs), and then wipe with an alcohol scrub pad (perform three times). 
		&#8203;NOTE: Remove the fur and clean the skin around the injection site and use sterile instruments and needles, as recommended by the American Veterinary Medical Association to prevent infections.</li>
	</ol>
	</li>
	<li>Firmly hold the head of the mouse with the non-dominant hand. Position the head as flat on the work surface as possible.</li>
	<li>Locate the site of the injection.
	<ol>
		<li>Use the prepared sharp 18 G needle to first identify bregma; for this, drag the needle across the skin of the head along the midline, moving in the rostral-caudal plane. Imagine an equilateral triangle in which the two vertices are the eyes and the third vertex is the approximate location of bregma (see Figure 1C).</li>
		<li>From bregma, move the needle 2 mm lateral and 1 mm caudal to the site of injection.</li>
	</ol>
	</li>
	<li>While holding the needle vertically, firmly push the needle through the skin and bone until the tubing is flush with the skin.</li>
	<li>Retract the needle, rotate the needle, and press through the skin and bone again. Repeat the process until a small hole is created in the bone.</li>
	<li>Use the blunt needle to check that a sufficient hole has been produced in the bone. Aim to make an opening in the bone large enough for the blunt needle to pass through.</li>
	<li>Remove the mouse from the nose cone, clean off any blood from the injection site with sterile gauze, and place the mouse in a cage on a cage warmer until awake. Since the opening made by the craniotomy is small (18 G needle), the site does not need to be closed with a suture or wound clips. 
	NOTE: The opening produced here is small (18 G), so many institutions consider this procedure an injection as opposed to a surgery. Moreover, although an opening through skin and bone to the brain is made, holding the skin taut results in the holes not aligning, which likely aids in preventing skin flora or cage bedding from contacting the brain.</li>
</ol>
2. Making the injection
<ol>
	<li>Prepare the materials for the injection as described below.
	<ol>
		<li>Place a clean bench pad or drape material on the work surface. Tape the nose cone of an isoflurane vaporizer to the work surface (close to, but facing away from, the experimenter; see Figure 1A).</li>
		<li>Attach a 10 mm long 27 G needle with a 45&#176; bevel onto a 5 &#181;L glass syringe. Place silastic tubing on the needle so that 3.5 mm of the needle tip protrudes; use laboratory tape to hold the tubing to the syringe body (see Figure 1D).</li>
		<li>Prepare the injection media (drug, virus, or other liquid for injection) in a tube. For the representative results in this study, sterile isotonic saline was injected. 
		NOTE: Select a tube that permits access by the glass syringe and needle, such as a 2 mL microcentrifuge tube.</li>
		<li>Draw 3 &#181;L of injection media into the glass syringe. First, draw more than the desired volume, and eject until 3 &#181;L remains in the syringe.</li>
		<li>Gather iodine scrub, sterile gauze, and alcohol pads for preparing the injection site.</li>
		<li>Start a laboratory timer in count-up mode and place the timer so that it is visible to the experimenter while making injections.</li>
		<li>Practice moving a needle 2 mm lateral and 1 mm caudal as performed on the previous day.</li>
	</ol>
	</li>
	<li>Prepare the mouse for injection as described below.
	<ol>
		<li>Place the mouse in the induction chamber and anesthetize the mouse with isoflurane. Once the toe reflex is absent, apply eye lubricant, and place the mouse on the work surface with the head in the nose cone.</li>
		<li>Clean the injection site with three wipes each of iodine and alcohol. Identify the injection site with an 18 G needle (or blunted needle) as described in step 1.8. The hole created during craniotomy should be detectable. 
		NOTE: If the craniotomy has not been performed in advance, or if the hole in the skull is not detectable, the craniotomy can be performed here.</li>
	</ol>
	</li>
	<li>Perform the injection with a glass syringe as described below.
	<ol>
		<li>Firmly hold the head of the mouse with the non-dominant hand. Position the head as flat on the work surface as possible.</li>
		<li>Place the needle of the glass syringe through the hole in the skull until the tubing placed over the needle prepared in step 2.1.2 rests on the skin of the mouse.</li>
		<li>Hold the syringe as vertically as possible, paying attention to both the coronal and sagittal planes. Slowly inject the media over a period of 1 min.</li>
		<li>Hold the syringe and needle in place for another minute after the completion of the injection to minimize backflow. Slowly retract the needle from the head of the mouse.</li>
		<li>Remove the mouse from the nose cone, clean off any blood from the injection site with sterile gauze (if there is any present), and place the mouse in a cage on a cage warmer until awake.</li>
	</ol>
	</li>
</ol>
3. Confirming the injection location
<ol>
	<li>Deeply anesthetize and perfuse the mouse with saline and 4% paraformaldehyde in phosphate-buffered saline (PBS) as previously described8. Store the brain in 30% sucrose in PBS at 4 &#176;C until the brain sinks (typically 2 days).</li>
	<li>Cut 20-50 &#181;m coronal sections on a cryostat as described previously9. While sectioning, observe the injection tract in the tissue block. Record whether the injection tract clearly intersects the lateral ventricle.</li>
</ol>

Performing Intracerebroventricular Injection in Mice Using a Free-Hand Approach

<ol>
	<li>Roseweir, A. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Discovery+of+potent+kisspeptin+antagonists+delineate+physiological+mechanisms+of+gonadotropin+regulation.">Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation.</a> Journal of Neuroscience. 29 (12), 3920-3929 (2009).</li><li>Kim, J. Y., Grunke, S. D., Levites, Y., Golde, T. E., Jankowsky, J. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intracerebroventricular+viral+injection+of+the+neonatal+mouse+brain+for+persistent+and+widespread+neuronal+transduction.">Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction.</a> Journal of Visualized Experiments. (91), e51863 (2014).</li><li>Taylor, Z. V., Khand, B., Porgador, A., Monsonego, A., Eremenko, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+optimized+intracerebroventricular+injection+of+CD4(+)+T+cells+into+mice.">An optimized intracerebroventricular injection of CD4(+) T cells into mice.</a> STAR Protocols. 2 (3), 100725 (2021).</li><li>Russo, K. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Circadian+control+of+the+female+reproductive+axis+through+gated+responsiveness+of+the+RFRP-3+system+to+VIP+signaling.">Circadian control of the female reproductive axis through gated responsiveness of the RFRP-3 system to VIP signaling.</a> Endocrinology. 156 (7), 2608-2618 (2015).</li><li>Laursen, S. E., Belknap, J. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intracerebroventricular+injections+in+mice.+Some+methodological+refinements.">Intracerebroventricular injections in mice. Some methodological refinements.</a> Journal of Pharmacological Methods. 16 (4), 355-357 (1986).</li><li>Haley, T. J., McCormick, W. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pharmacological+effects+produced+by+intracerebral+injection+of+drugs+in+the+conscious+mouse.">Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.</a> British Journal of Pharmacology and Chemotherapy. 12 (1), 12-15 (1957).</li><li>McCosh, R. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Insulin-induced+hypoglycaemia+suppresses+pulsatile+luteinising+hormone+secretion+and+arcuate+Kiss1+cell+activation+in+female+mice.">Insulin-induced hypoglycaemia suppresses pulsatile luteinising hormone secretion and arcuate Kiss1 cell activation in female mice.</a> Journal of Neuroendocrinology. 31 (12), e12813 (2019).</li><li>Wu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transcardiac+perfusion+of+the+mouse+for+brain+tissue+dissection+and+fixation.">Transcardiac perfusion of the mouse for brain tissue dissection and fixation.</a> Bio-Protocol. 11 (5), e3988 (2021).</li><li>Comba, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Laser+capture+microdissection+of+glioma+subregions+for+spatial+and+molecular+characterization+of+intratumoral+heterogeneity,+oncostreams,+and+invasion.">Laser capture microdissection of glioma subregions for spatial and molecular characterization of intratumoral heterogeneity, oncostreams, and invasion.</a> Journal of Visual Experiments. (158), e60939 (2020).</li><li>Porteous, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Reformulation+of+PULSAR+for+analysis+of+pulsatile+LH+secretion+and+a+revised+model+of+estrogen-negative+feedback+in+mice.">Reformulation of PULSAR for analysis of pulsatile LH secretion and a revised model of estrogen-negative feedback in mice.</a> Endocrinology. 162 (11), (2021).</li><li>Hohmann, J. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+role+of+melanocortins+in+mediating+leptin's+central+effects+on+feeding+and+reproduction.">Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction.</a> American Journal of Physiology: Regulatory, Integrative, and Comparative Physiology. 278 (1), R50-R59 (2000).</li><li>Gottsch, M. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+role+for+kisspeptins+in+the+regulation+of+gonadotropin+secretion+in+the+mouse.">A role for kisspeptins in the regulation of gonadotropin secretion in the mouse.</a> Endocrinology. 145 (9), 4073-4077 (2004).</li><li>Krasnow, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+role+for+galanin-like+peptide+in+the+integration+of+feeding,+body+weight+regulation,+and+reproduction+in+the+mouse.">A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse.</a> Endocrinology. 144 (3), 813-822 (2003).</li></ol>

The authors have nothing to disclose.

Here, a simple and effective means for making ICV injections in mice is described. Since this technique does not require a stereotaxic frame, this approach for the central delivery of drugs and experimental agents is accessible to more researchers. Additionally, this approach is relatively high throughput since the preparation and injection procedure can be performed quickly.
Since this procedure requires the manipulation of needles and a glass syringe by hand using approximate distances, it i...

The delivery of experimental agents, such as drugs1, viruses2, or cells3, to the brain is often necessary for neuroendocrine research. If the agent does not readily cross the blood-brain barrier or the experimental objective is to specifically test the central effects of the agent, it is important to have a reliable method for delivering injections into the brain. Moreover, injection into the intracerebroventricular (ICV) space provides the opportunity to distribute the agent widely in the brain and provides a large target area, thus increasing the likelihood of successful injection2. 
A common method for making ICV injections involves the placement of a permanent indwelling cannula. In this approach, a stereotaxic frame is necessary to position the commercially available or custom-made cannula, as the cannula is glued or cemented in place. Often, upon recovery, a supraphysiological dose of angiotensin II is administered through the cannula, and if drinking behavior is immediately observed, then the cannula is considered correctly placed4. This approach has many advantages, including the ability to perform long-term infusion and the ability to inject the same animal multiple times; additionally, if angiotensin II is employed, correct placement can be confirmed prior to the administration of experimental compounds. However, there are some limitations to placing a permanent cannula, including the requirement for expensive equipment (stereotaxic frame), the possibility of damage to the cannula after placement (e.g., mice can chew on the cannula of a cage mate), and the possibility of infections around the permanent cannula. Single ICV injections can be made with the use of a stereotaxic frame3, which, although effective, requires substantial exposure to anesthesia and, thus, may obscure some acute physiological and behavioral effects of the treatment. Additionally, the placement of mice in a stereotaxic frame requires substantial training to achieve stable placement and prevent the rupturing of the ear canals.
Here, an established method for making free-hand injections in mice is described. This method is based on previous reports5,6. The advantages of this technique are that it is simple, rapid, and does not require specialized equipment such as a stereotaxic frame. As described below, this procedure involves manipulating a glass syringe relative to landmarks on the mouse head to make the injections, which can be done rapidly and, thus, requires only a few minutes of gas anesthesia on the experimental day.

<table><tbody><tr><td>18-gauge blunt needles</td><td>SAI Infusion</td><td>B18-150</td><td></td></tr><tr><td>18-gauge needles</td><td>BD Medical</td><td>305195</td><td></td></tr><tr><td>Alcohol pads</td><td>Fisher Scientific</td><td>22-363-750</td><td></td></tr><tr><td>Bench pad</td><td>Fisher Scientific</td><td>14-206-62AC22</td><td></td></tr><tr><td>Betadine solution</td><td>Fisher Scientific</td><td>NC1696484</td><td></td></tr><tr><td>Buprenorphine</td><td>Patterson Vet Supply</td><td>07-892-5235</td><td>Controlled substance</td></tr><tr><td>Eyelube</td><td>Fisher Scientific</td><td>50-218-8442</td><td></td></tr><tr><td>Glass syringe</td><td>Hamilton</td><td>7634-01</td><td></td></tr><tr><td>Injection needle</td><td>Hamilton</td><td>7803-01</td><td>27 gauge, Small Hub RN needle, point style: 4, Needle length: 10cm, Angle: 45</td></tr><tr><td>Isoflurane&amp;nbsp;&amp;nbsp;</td><td>Patterson Vet Supply</td><td>07-893-8441</td><td></td></tr><tr><td>Isoflurane vaporizer</td><td>Vet Equip</td><td>V-10</td><td></td></tr><tr><td>Laboratory Tape</td><td>VWR</td><td>89098-128</td><td></td></tr><tr><td>Medical grade oxygen</td><td>Airgas</td><td>OX USPEA</td><td></td></tr><tr><td>Paraformaldehyde</td><td>Millipore-Sigma</td><td>8.18715.1000</td><td></td></tr><tr><td>Phosphate Buffered Saline</td><td>Fisher Scientific</td><td>J67802.K2</td><td></td></tr><tr><td>PulsaR Software</td><td>Open source, University of Otago</td><td></td><td>See ref 9</td></tr><tr><td>Ruler</td><td>Fisher Scientific</td><td>12-00-152</td><td></td></tr><tr><td>Silastic tubing (0.040&quot; I.D.)</td><td>DOW</td><td>508-005</td><td></td></tr><tr><td>Silastic tubing (0.078&quot; I.D.)</td><td>DOW</td><td>508-009</td><td></td></tr><tr><td>Sterile saline</td><td>VWR</td><td>101320-574</td><td></td></tr><tr><td>Sucrose&amp;nbsp;</td><td>Fisher Scientific</td><td>S5-500</td><td></td></tr></tbody></table>

free-hand intracerebroventricular injections in mice

The investigation of neuroendocrine systems often requires the delivery of drugs, viruses, or other experimental agents directly into the brains of mice. An intracerebroventricular (ICV) injection allows the widespread delivery of the experimental agent throughout the brain (particularly in the structures near the ventricles). Here, methods for making free-hand ICV injections in adult mice are described. By using visual and tactile landmarks on the heads of mice, injections into the lateral ventricles can be made rapidly and reliably. The injections are made with a glass syringe held in the experimenter&#39;s hand and placed at approximate distances from the landmarks. Thus, this technique does not require a stereotaxic frame. Furthermore, this technique requires only brief isoflurane anesthesia, which permits the subsequent assessment of mouse behavior and/or physiology in awake, freely behaving mice. Free-hand ICV injection is a powerful tool for the efficient delivery of experimental agents into the brains of living mice and can be combined with other techniques such as frequent blood sampling, neural circuit manipulation, or in vivo recording to investigate neuroendocrine processes.

When performed successfully, this technique allows the rapid delivery of an experimental agent into the ventricular system. A luteinizing hormone (LH) pulse profile from an ovariectomized mouse that received an ICV injection of 3 µL of sterile isotonic saline, the vehicle for many pharmacological compounds, is shown in Figure 2A. This example demonstrates that brief exposure to gas anesthesia and the injection of 3 µL of fluid into the ventricular system alone did not alter the pulsatile L...

Watch this Scientific Journal Video about Insights, Innovations, and Future Avenues in Reproductive Neurocontrol at JoVE.com

Author Spotlight: Insights, Innovations, and Future Avenues in Reproductive Neurocontrol 

Here, a simple and rapid approach for performing intracerebroventricular injections in mice using a free-hand approach (that is, without a stereotaxic device) is described.

Free-Hand Intracerebroventricular Injections in Mice

The investigation of neuroendocrine systems often requires the delivery of drugs, viruses, or other experimental agents directly into the brains of mice. ...

free-hand-intracerebroventricular-injections-in-mice

Research

JoVE Journal

Neuroscience

10.5K Views.  Colorado State University. Here, a simple and rapid approach for performing intracerebroventricular injections in mice using a free-hand approach (that is, without a stereotaxic device) is described.

Video: Author Spotlight: Insights, Innovations, and Future Avenues in Reproductive Neurocontrol 

Isolation of Brain-infiltrating Leukocytes

We describe a method for preparing brain infiltrating leukocytes (BILs) from mice. We demonstrate how to infect mice with Theiler's murine encephalomyelitis virus (TMEV) via a rapid intracranial injection technique and how to purify a leukocyte-enriched population of infiltrating cells from whole brain. Briefly, mice are anesthetized with isoflurane in a closed chamber and are free-hand injected with a Hamilton syringe into the frontal cortex. Mice are then killed at various times after infection by isoflurane overdose and whole brains are extracted and homogenized in RPMI with a Tenbroeck tissue grinder. Brain homogenates are centrifuged through a continuous 30% Percoll gradient to remove the myelin and other cell debris. The cell suspension is then strained at 40 &mu;m, washed and centrifuged on a discontinuous Ficoll-Paque Plus gradient to select and purify the leukocytes. The leukocytes are then washed and resuspended in appropriate buffers for immunophenotyping by flow cytometry. Flow cytometry reveals a population of innate immune cells at the early stages of infection in C57BL/6 mice. At 24 hours post infection, multiple subsets of immune cells are present in the BILs, with an enriched population of Gr1+, CD11b+ and F4/80+cells. Therefore, this method is useful in characterizing the immune response to acute infection in the brain.

A rapid method to obtain infiltrating leukocytes from the murine brain is described. This method utilizes a continuous Percoll gradient and discontinuous Ficoll gradient to select and purify the leukocyte-enriched layer. Isolated leukocytes may then be characterized by flow cytometric measurements.

We describe a method for preparing brain infiltrating leukocytes (BILs) from mice. We demonstrate how to infect mice with Theiler's murine ...

Immunology and Infection

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

Despite the protective role that blood brain barrier plays in shielding the brain, it limits the access to the central nervous system (CNS) which most often results in failure of potential therapeutics designed for neurodegenerative disorders 1,2. Neurodegenerative diseases such as Spinal Muscular Atrophy (SMA), in which the lower motor neurons are affected, can benefit greatly from introducing the therapeutic agents into the CNS. The purpose of this video is to demonstrate two different injection paradigms to deliver therapeutic materials into neonatal mice soon after birth. One of these methods is injecting directly into cerebral lateral ventricles (Intracerebroventricular) which results in delivery of materials into the CNS through the cerebrospinal fluid 3,4. The second method is a temporal vein injection (intravenous) that can introduce different therapeutics into the circulatory system, leading to systemic delivery including the CNS 5. Widespread transduction of the CNS is achievable if an appropriate viral vector and viral serotype is utilized. Visualization and utilization of the temporal vein for injection is feasible up to postnatal day 6. However, if the delivered material is intended to reach the CNS, these injections should take place while the blood brain barrier is more permeable due to its immature status, preferably prior to postnatal day 2. The fully developed blood brain barrier greatly limits the effectiveness of intravenous delivery. Both delivery systems are simple and effective once the surgical aptitude is achieved. They do not require any extensive surgical devices and can be performed by a single person. However, these techniques are not without challenges. The small size of postnatal day 2 pups and the subsequent small target areas can make the injections difficult to perform and initially challenging to replicate.

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

This article demonstrates two very different methods of injection: 1) into the brain (intracerebroventricular) and 2) systemic (intravenous) to introduce the therapeutic agents into the central nervous system of neonatal mice.

Despite the protective role that blood brain barrier plays in shielding the brain, it limits the access to the central nervous system (CNS) which most ...

Medicine

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Investigation of the pathophysiology of injury after intracerebral
hemorrhage (ICH) requires a reproducible animal model. While ICH
accounts for 10-15% of all strokes, there remains no specific
effective therapy. The autologous blood injection model in mice
involves the stereotaxic injection of arterial blood into the basal
ganglia mimicking a spontaneous hypertensive hemorrhage in man. The
response to hemorrhage can then be studied in vivo and the
neurobehavioral deficits quantified, allowing for description of the
ensuing pathology and the testing of potential therapeutic agents. The
procedure described in this protocol uses the double injection
technique to minimize risk of blood reflux up the needle track, no
anticoagulants in the pumping system, and eliminates all dead space
and expandable tubing in the system.

The autologous blood injection model of intracerebral hemorrhage in mice described in this protocol uses the double injection technique to minimize risk of blood reflux up the needle track, no anticoagulants in the pumping system, and eliminates all dead space and expandable tubing in the system.

Investigation of the pathophysiology of injury after intracerebral
hemorrhage (ICH) requires a reproducible animal model.  While ICH
accounts for 10-15% ...

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

With the pace of scientific advancement accelerating rapidly, new methods are needed for experimental neuroscience to quickly and easily manipulate gene expression in the mouse brain. Here we describe a technique first introduced by Passini and Wolfe for direct intracranial delivery of virally-encoded transgenes into the neonatal mouse brain. In its most basic form, the procedure requires only an ice bucket and a microliter syringe. However, the protocol can also be adapted for use with stereotaxic frames to improve consistency for researchers new to the technique. The method relies on the ability of adeno-associated virus (AAV) to move freely from the cerebral ventricles into the brain parenchyma while the ependymal lining is still immature during the first 12-24 hr after birth. Intraventricular injection of AAV at this age results in widespread transduction of neurons throughout the brain. Expression begins within days of injection and persists for the lifetime of the animal. Viral titer can be adjusted to control the density of transduced neurons, while co-expression of a fluorescent protein provides a vital label of transduced cells. With the rising availability of viral core facilities to provide both off-the-shelf, pre-packaged reagents and custom viral preparation, this approach offers a timely method for manipulating gene expression in the mouse brain that is fast, easy, and far less expensive than traditional germline engineering.

Here we demonstrate a technique for widespread neuronal transduction by intraventricular injection of adeno-associated virus into the neonatal mouse brain. This method provides a rapid and easy way to attain lifelong expression of virally-delivered transgenes.

With the pace of scientific advancement accelerating rapidly, new methods are needed for experimental neuroscience to quickly and easily manipulate gene ...

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

In the study on the pathogenesis of viral encephalitis, the infection method is critical. The first of the two main infectious routes to the brain is the hematogenous route, which involves infection of the endothelial cells and pericytes of the brain. The second is the intracerebroventricular (ICV) route. Once within the central nervous system (CNS), viruses may spread to the subarachnoid space, meninges, and choroid plexus via the cerebrospinal fluid. In experimental models, the earliest stages of CNS viral distribution are not well characterized, and it is unclear whether only certain cells are initially infected. Here, we have analyzed the distribution of cytomegalovirus (CMV) particles during the acute phase of infection, termed primary viremia, following ICV or intravascular (IV) injection into the neonatal mouse brain. In the ICV injection model, 5 &#181;l of murine CMV (MCMV) or fluorescent microbeads were injected into the lateral ventricle at the midpoint between the ear and eye using a 10-&#181;l syringe with a 27 G needle. In the IV injection model, a 1-ml syringe with a 35 G needle was used. A transilluminator was used to visualize the superficial temporal (facial) vein of the neonatal mouse. We infused 50 &#181;l of MCMV or fluorescent microbeads into the superficial temporal vein. Brains were harvested at different time points post-injection. MCMV genomes were detected using the in situ hybridization method. Fluorescent microbeads or green fluorescent protein expressing recombinant MCMV particles were observed by fluorescent microscopy. These techniques can be applied to many other pathogens to investigate the pathogenesis of encephalitis.

Here, we describe a simple method of intracerebroventricular and intravascular injection of viral particles or fluorescent microbeads into the neonatal mouse brain. The localization pattern of the virus and nanoparticles could be detected by microscopic evaluation or by in situ hybridization.

In the study on the pathogenesis of viral encephalitis, the infection method is critical. The first of the two main infectious routes to the brain is the ...

Personalized Needles for Microinjections in the Rodent Brain

Microinjections have been used for a long time for the delivery of drugs or toxins within specific brain areas and, more recently, they have been used to deliver gene or cell therapy products. Unfortunately, current microinjection techniques use steel or glass needles that are suboptimal for multiple reasons: in particular, steel needles may cause tissue damage, and glass needles may bend when lowered deeply into the brain, missing the target region. In this article, we describe a protocol to prepare and use quartz needles that combine a number of useful features. These needles do not produce detectable tissue damage and, being very rigid, ensure reliable delivery in the desired brain region even when using deep coordinates. Moreover, it is possible to personalize the design of the needle by making multiple holes of the desired diameter. Multiple holes facilitate the injection of large amounts of solution within a larger area, whereas large holes facilitate the injection of cells. In addition, these quartz needles can be cleaned and re-used, such that the procedure becomes cost-effective.

We describe here a protocol for microinjection in the rodent brain that uses quartz needles. These needles do not produce detectable tissue damage and ensure reliable delivery even in deep regions. Moreover, they can be adapted to research needs by personalized designs and can be re-used.

Microinjections have been used for a long time for the delivery of drugs or toxins within specific brain areas and, more recently, they have been used to ...

Intravenous Injections in Neonatal Mice

Intravenous injection is a clinically applicable manner to deliver therapeutics. For adult rodents and larger animals, intravenous injections are technically feasible and routine. However, some mouse models can have early onset of disease with a rapid progression that makes administration of potential therapies difficult. The temporal (or facial) vein is just anterior to the ear bud in mice and is clearly visible for the first two days after birth on either side of the head using a dissecting microscope. During this window, the temporal vein can be injected with volumes up to 50 &#956;l. The injection is safe and well tolerated by both the pups and the dams. A typical injection procedure is completed within 1-2 min, after which the pup is returned to the home cage. By the third postnatal day the vein is difficult to visualize and the injection procedure becomes technically unreliable. This technique has been used for delivery of adeno-associated virus (AAV) vectors, which in turn can provide almost body-wide, stable transgene expression for the life of the animal depending on the viral serotype chosen.

Animal models of pediatric disease can experience early onset and aggressive disease progression. Clinically relevant therapy delivery to young mouse models can be technically difficult. This protocol describes a non-invasive intravenous injection method for newborn mice within the first two postnatal days of life.

Intravenous injection is a clinically applicable manner to deliver therapeutics. For adult rodents and larger animals, intravenous injections are ...

Biology

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

The impact of gut microbiota and their metabolites on host physiology and behavior has been extensively investigated in this decade. Numerous studies have revealed that gut microbiota-derived metabolites modulate brain-mediated physiological functions through intricate gut-brain pathways in the host. Short-chain fatty acids (SCFAs) are the major bacteria-derived metabolites produced during dietary fiber fermentation by the gut microbiome. Secreted SCFAs from the gut can act at multiple sites in the periphery, affecting the immune, endocrine, and neural responses due to the vast distribution of SCFAs receptors. Therefore, it is challenging to differentiate the central and peripheral effects of SCFAs through oral and intraperitoneal administration of SCFAs. This paper presents a video-based method to interrogate the functional role of SCFAs in the brain via a guide cannula in freely moving mice. The amount and type of SCFAs in the brain can be adjusted by controlling the infusion volume and rate. This method can provide scientists with a way to appreciate the role of gut-derived metabolites in the brain.

Gut-derived microbial metabolites have multifaceted effects leading to complex behavior in animals. We aim to provide a step-by-step method to delineate the effects of gut-derived microbial metabolites in the brain via intracerebroventricular delivery via a guide cannula.

The impact of gut microbiota and their metabolites on host physiology and behavior has been extensively investigated in this decade. Numerous studies have ...

Handling-Induced Seizures in a Mouse Model

Source: Batot, G., et al. <a href="https://app.jove.com/v/63673">A Model for Epilepsy of Infectious Etiology using Theiler&#39;s Murine Encephalomyelitis Virus.</a>&#160;J. Vis. Exp. (2022).
This video demonstrates the induction of handling-induced seizures in a mouse infected with Theiler&#39;s Murine Encephalomyelitis Virus (TMEV). The infected mouse, which has hyperexcitable neurons, is exposed to external physical stimuli. This exposure causes stress, leading to abnormal electrical activity in the neurons, which results in seizures.

Source: Batot, G., et al. A Model for Epilepsy of Infectious Etiology using Theiler&#39;s Murine Encephalomyelitis Virus.&#160;J. Vis. Exp. (2022).
This ...

JoVE Encyclopedia of Experiments

Neuropathology

Epilepsy and Seizure Disorders

Glioblastoma Induction Using SB Mediated Transposition: A Technique for Generating Novel Mouse Model Using Transposon Mediated Integration of SB Plasmid into Neonatal Mouse Brain

Source: Calinescu, A. A. et al. <a href="https://www.jove.com/video/52443" target="_blank">Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma.</a> J. Vis. Exp. (2015)
This video describes an efficient technique to induce glioblastomas (GBM) using transposon DNA injected into the ventricles of neonatal mice. Cells of the subventricular zone, which take up the plasmid, transform, proliferate, and generate tumors with histopathological characteristics of human GBM.

Source: Calinescu, A. A. et al. Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of ...